| Tiffany Lynn Gies, APRN/FNP-C | |
|
2101 Box Butte Ave, Alliance, NE 69301-4445 | |
| (308) 762-6660 | |
| Not Available |
| Full Name | Tiffany Lynn Gies |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 2101 Box Butte Ave, Alliance, Nebraska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801508494 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | F11220445 (Nebraska) | Primary |
| Entity Name | Box Butte General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871652453 PECOS PAC ID: 9638089584 Enrollment ID: O20031218000378 |
News Archive
According to the Chinese media, 87 people are now infected with meningitis after eating undercooked snails at a Beijing restaurant.
Detecting dangerous blood clots, which can cause life-threatening conditions such as strokes and heart attacks, leading causes of death for men and women in the U.S., has been a coveted and elusive goal.
Isis Pharmaceuticals, Inc. today announced that it will receive a $10 million payment from OncoGenex Pharmaceuticals, Inc. as a result of OncoGenex' license of OGX-011 to Teva Pharmaceutical Industries Ltd. ( TEVA). OGX-011 is a second-generation antisense drug co-discovered by Isis and OncoGenex that has completed a successful Phase 2 program in patients with advanced prostate cancer and advanced non-small cell lung cancer.
An article published in Experimental Biology and Medicine (Volume 242, Issue 12, June, 2017) links imbalances in lipoprotein metabolism with vaso-occlusive events in patients with sickle cell disease
USAID announced on Thursday a $1 million commitment to a Red Cross project aimed at helping those "living along southern Africa's Zambezi River cope with worsening natural disasters because of climate change," the AP/Washington Post reports.
› Verified 8 days ago
| Entity Name | Box Butte General Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1811929060 PECOS PAC ID: 9638089584 Enrollment ID: O20061104000247 |
News Archive
According to the Chinese media, 87 people are now infected with meningitis after eating undercooked snails at a Beijing restaurant.
Detecting dangerous blood clots, which can cause life-threatening conditions such as strokes and heart attacks, leading causes of death for men and women in the U.S., has been a coveted and elusive goal.
Isis Pharmaceuticals, Inc. today announced that it will receive a $10 million payment from OncoGenex Pharmaceuticals, Inc. as a result of OncoGenex' license of OGX-011 to Teva Pharmaceutical Industries Ltd. ( TEVA). OGX-011 is a second-generation antisense drug co-discovered by Isis and OncoGenex that has completed a successful Phase 2 program in patients with advanced prostate cancer and advanced non-small cell lung cancer.
An article published in Experimental Biology and Medicine (Volume 242, Issue 12, June, 2017) links imbalances in lipoprotein metabolism with vaso-occlusive events in patients with sickle cell disease
USAID announced on Thursday a $1 million commitment to a Red Cross project aimed at helping those "living along southern Africa's Zambezi River cope with worsening natural disasters because of climate change," the AP/Washington Post reports.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tiffany Lynn Gies, APRN/FNP-C 871 Cobbler Ln, Sutherland, NE 69165-7261 Ph: (308) 520-6001 | Tiffany Lynn Gies, APRN/FNP-C 2101 Box Butte Ave, Alliance, NE 69301-4445 Ph: (308) 762-6660 |
News Archive
According to the Chinese media, 87 people are now infected with meningitis after eating undercooked snails at a Beijing restaurant.
Detecting dangerous blood clots, which can cause life-threatening conditions such as strokes and heart attacks, leading causes of death for men and women in the U.S., has been a coveted and elusive goal.
Isis Pharmaceuticals, Inc. today announced that it will receive a $10 million payment from OncoGenex Pharmaceuticals, Inc. as a result of OncoGenex' license of OGX-011 to Teva Pharmaceutical Industries Ltd. ( TEVA). OGX-011 is a second-generation antisense drug co-discovered by Isis and OncoGenex that has completed a successful Phase 2 program in patients with advanced prostate cancer and advanced non-small cell lung cancer.
An article published in Experimental Biology and Medicine (Volume 242, Issue 12, June, 2017) links imbalances in lipoprotein metabolism with vaso-occlusive events in patients with sickle cell disease
USAID announced on Thursday a $1 million commitment to a Red Cross project aimed at helping those "living along southern Africa's Zambezi River cope with worsening natural disasters because of climate change," the AP/Washington Post reports.
› Verified 8 days ago
Sally Beth Bryner, MSN, PRN,FNP-BD,CLC Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2091 Box Butte Ave, Suite 500, Alliance, NE 69301 Phone: 308-762-2534 Fax: 308-762-2764 | |
Bruce Dwayne Forney, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2307 Box Butte Ave, Alliance, NE 69301 Phone: 308-762-3741 Fax: 308-762-7743 | |
Mr. Lonnie L Grant, PA-C Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2107 Box Butte Ave, Alliance, NE 69301 Phone: 308-762-7244 Fax: 308-762-6657 | |
Jessica Ann Ott, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2101 Box Butte Ave Ste 700, Alliance, NE 69301 Phone: 308-762-7244 |